Home›Search›Drugs and Therapy Perspectives

Drugs and Therapy Perspectives

Adis International Ltd · United Kingdom · Est. 1993

ISSN1179-1977

SJR Q3✓ WOS ESCI✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.204

H-Indexi

SNIPi

0.194

Total Worksi

3,558

Total Citationsi

3,949

2yr Mean Citednessi

0.46

Open Impact Factor alternative

Aims & Scope

Drugs & Therapy Perspectives supports healthcare professionals working in clinical settings by publishing concise, authoritative review articles to aid drug formulary and treatment decisions, and original research articles on all aspects of pharmacological treatment to promote optimal patient outcomes.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1993

Annual Volume~ 79 articles / year

StatusActive (last: 2026)

Total Publications3,558

Publisher OrgAdis, Springer Healthcare

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Adis International Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1179-1977

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

106

259

2019

101

1.6k

2020

248

2021

255

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology (medical)Q3

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)

Research Topics (OpenAlex)

Pharmaceutical studies and practicesPharmacovigilance and Adverse Drug ReactionsPharmaceutical Practices and Patient OutcomesPharmaceutical industry and healthcarePharmacological Effects and Toxicity StudiesAsthma and respiratory diseasesSchizophrenia research and treatmentEconomic, financial, and policy analysisBiotechnology and Related FieldsHealth Systems, Economic Evaluations, Quality of Life

Frequently asked questions about Drugs and Therapy Perspectives

Is Drugs and Therapy Perspectives a predatory journal?

PubScope has no integrity flags on record for Drugs and Therapy Perspectives: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Drugs and Therapy Perspectives?

Drugs and Therapy Perspectives is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.46.

Is Drugs and Therapy Perspectives indexed in Scopus and Web of Science?

Drugs and Therapy Perspectives is indexed in Web of Science, Scopus.